Keyword: North Carolina

North Carolina is providing some financial assistance for the construction of Audentes gene therapy facility in Sanford, North Carolina.

With momentum building in Pfizer’s gene therapy programs, it has bought a building in North Carolina where it will consolidate clinical manufacturing.

Precision BioSciences says it will have a manufacturing facility for its off-the-shelf CAR-T therapies up and running in the fourth quarter.

KriGen Pharmaceuticals plans to build a $7 million facility in Lillington, North Carolina.

Within two years, Novo says it will power it entire production network with solar, wind or water power.

With two-thirds of its customers in the U.S., Sterling Pharma Solutions decided to buy a facility there.

Seqirus plans to add cell-based and adjuvanted flu vaccine capacity in a $140 million expansion to its plant in Holly Springs, North Carolina.

U.K.-based CDMO Almac is adding to its U.S. operations with a new building at its site in North Carolina where it says it will house 100 new employees.

CSL's flu vaccine unit Seqirus posted $1.09 billion in sales during its 2018 fiscal year and turned in its first-ever profit.

North Carolina-based drug manufacturer Panaceutics said it will invest $5.8 million in a facility in Pittsylvania County, Virginia.